4DMedical is trading at A$2.41, down 7.31%, with the reason for the November 3 decline unclear.
- No new company-specific catalyst for November 3 was identified.
- In its November 2 ASX response, the company said it knew of no undisclosed information. Coverage linked the earlier sell-off to increased short interest, not a new announcement today.
- The S&P 500 and Nasdaq were higher, so broad-market weakness does not explain the decline.